GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pacira BioSciences Inc (STU:82P) » Definitions » Short-Term Capital Lease Obligation

Pacira BioSciences (STU:82P) Short-Term Capital Lease Obligation : €8.3 Mil (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Pacira BioSciences Short-Term Capital Lease Obligation?

Pacira BioSciences's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €8.3 Mil.

Pacira BioSciences's quarterly Short-Term Capital Lease Obligation declined from Sep. 2023 (€8.1 Mil) to Dec. 2023 (€8.1 Mil) but then increased from Dec. 2023 (€8.1 Mil) to Mar. 2024 (€8.3 Mil).

Pacira BioSciences's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (€7.0 Mil) to Dec. 2022 (€8.6 Mil) but then declined from Dec. 2022 (€8.6 Mil) to Dec. 2023 (€8.1 Mil).


Pacira BioSciences Short-Term Capital Lease Obligation Historical Data

The historical data trend for Pacira BioSciences's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacira BioSciences Short-Term Capital Lease Obligation Chart

Pacira BioSciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.44 6.10 6.98 8.61 8.07

Pacira BioSciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.36 8.29 8.08 8.07 8.28

Pacira BioSciences Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


Pacira BioSciences Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Pacira BioSciences's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacira BioSciences (STU:82P) Business Description

Industry
Traded in Other Exchanges
Address
5401 West Kennedy Boulevard, Suite 890, Tampa, FL, USA, 33609
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.

Pacira BioSciences (STU:82P) Headlines

No Headlines